Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients

Terminated

• Conditions: Spinal Stenosis; Nerve Root Disorder; Radiculopathy, Cervical; Benign Hypermobility Syndrome; Low Back Pain, Mechanical
• Interventions: Other: Beighton score for hypermobility

• Registration Number: NCT02761928
• Lead Sponsor: The University of Texas Health Science Center, Houston

Brief Summary

Observational study of axial spine pain and hyperflexibility. Patients will receive physical exam maneuvers (traditional straight leg raise, FABER, facet loading as well as Beighton's hypermobility score) and blood / urine / saliva collection. They will also be separated into pain groups based on their response to injections. A correlation between exam findings and procedure group will be measured.

Detailed Description

This is an observational study of patients with neck and back pain followed by a pain management clinic. Patients with particular pain generators in the neck and back will be defined by a positive response to one of several targeted interventional pain procedures. Each patient may undergo a physical exam to determine whether they have hypermobile joints. The study will thus evaluate the rate of hypermobility for each pain generator. In addition blood, urine, or saliva samples may be taken for biomarkers for pain or rheumatologic factors.

Study Timeline

• Study Start: 2016-01
• Study First Submitted: 2016-04-24
• Study First Submitted QC: 2016-05-03
• Study First Posted: 2016-05-04
• Primary Completion: 2017-08-01
• Study Completion: 2017-08-01
• Status Verified: 2020-11
• Last Update Submitted: 2020-11-09
• Last Update Posted: 2020-11-12

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

• Clinical diagnosis of axial back pain (neck, mid-back, lower back) or pain radiating to the extremity, with suspected diagnosis of a specific pain generator amenable to a pain procedure, including disorders of the nerves, joints, and muscles as listed immediately below.

• Clinical decision to schedule patient for a pain procedure, including procedures targeting the following disorders:

  • Facet arthropathy: intra-articular facet joint injection, medial branch block, medial branch radiofrequency ablation
  • Sacroiliac joint dysfunction: sacroiliac joint injection, lateral branch block, lateral branch radiofrequency ablation
  • Myofascial pain syndrome: trigger point injection
  • Radiculopathy, spinal stenosis, or herniated nucleus pulposus: epidural steroid injection, selective nerve root block
  • Piriformis syndrome: piriformis injection
  • Greater trochanteric bursitis: greater trochanteric bursa injection

• Able to provide HIPAA authorization to share prior medical records/imaging.

Exclusion Criteria

• Previous diagnosis of cancer.
• Currently pregnant.
• Previously enrolled for the same procedure or the same pain generator site. (For example, this would exclude a patient who had an intra-articular facet joint injection at the right L5/S1 if: 1) he had the same injection 3 months ago and was enrolled at that time, or 2) the patient was already enrolled for a medial branch block at the right L5 and sacral ala, as this targets the same facet joint.)
• Inability or unwillingness of subject or legal guardian/representative to give informed consent (e.g., ward of the state)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Epidural	Beighton score for hypermobility	Positive response (\>50% pain relief) to any epidural (e.g. interlaminar/paramedian, transforaminal, caudal)
Selective nerve root block	Beighton score for hypermobility	Positive response (\>50% pain relief) to selective nerve root block
Facet injection	Beighton score for hypermobility	Positive response (\>50% pain relief) to intra-articular facet injection
Medial branch block	Beighton score for hypermobility	Positive response (\>50% pain relief) to median branch nerve block
Medial branch RFA	Beighton score for hypermobility	Positive response (\>50% pain relief) to median branch nerve radiofrequency ablation
SIJ injection	Beighton score for hypermobility	Positive response (\>50% pain relief) to sacroiliac joint injection
Lateral branch block	Beighton score for hypermobility	Positive response (\>50% pain relief) to lateral branch nerve block for SIJ
Greater trochanter injection	Beighton score for hypermobility	Positive response (\>50% pain relief) to greater trochanteric bursa injection
Piriformis injection	Beighton score for hypermobility	Positive response (\>50% pain relief) to piriformis injection
Trigger point injection	Beighton score for hypermobility	Positive response (\>50% pain relief) to trigger point injection

Primary Outcome Measures

Name	Time	Method
Beighton hypermobility score	Prior to injection (2 weeks prior to injection for each patient)	9 point standardized scale

Trial Locations

Locations (1)

University of Texas Health Science Center at Houston; 🇺🇸 Houston, Texas, United States